Cannabidiol for the prevention and treatment of graft-versus-host disease
AssigneeMor Research Applications Ltd.
InventorMoshe Yeshurun
Life of this patent
Estimating the term…
Abstract
The invention provides methods for preventing, ameliorating and treating the acute and chronic forms of graft-versus-host disease (GVHD) by using Cannabidiol compositions.
Claims12
A method of preventing, ameliorating or treating graft-versus-host disease (GVHD), comprising the step of administering to a patient undergoing transplantation, either within 14 days prior to transplantation or beginning 1 to 30 days after transplantation, an effective amount of a composition lacking psychotropic effects comprising cannabidiol in doses of cannabidiol between about 5 mg to about 600 mg each administration, once to three times daily.
A method of treating graft-versus-host disease (GVHD), comprising administering to a patient suffering from GVHD a therapeutically effective amount of a composition lacking psychotropic effects comprising cannabidiol in doses of cannabidiol between about 5 mg to about 600 mg each administration, once to three times daily.
Dependencies are inferred from the claim text.